125 related articles for article (PubMed ID: 18375581)
1. Modulation of cardiac performance by motor protein gene transfer.
Herron TJ; Devaney EJ; Metzger JM
Ann N Y Acad Sci; 2008 Mar; 1123():96-104. PubMed ID: 18375581
[TBL] [Abstract][Full Text] [Related]
2. Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer.
Herron TJ; Devaney E; Mundada L; Arden E; Day S; Guerrero-Serna G; Turner I; Westfall M; Metzger JM
FASEB J; 2010 Feb; 24(2):415-24. PubMed ID: 19801488
[TBL] [Abstract][Full Text] [Related]
3. Single cardiac ventricular myosins are autonomous motors.
Wang Y; Yuan CC; Kazmierczak K; Szczesna-Cordary D; Burghardt TP
Open Biol; 2018 Apr; 8(4):. PubMed ID: 29669825
[TBL] [Abstract][Full Text] [Related]
4. Identification of functional differences between recombinant human α and β cardiac myosin motors.
Deacon JC; Bloemink MJ; Rezavandi H; Geeves MA; Leinwand LA
Cell Mol Life Sci; 2012 Jul; 69(13):2261-77. PubMed ID: 22349210
[TBL] [Abstract][Full Text] [Related]
5. Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes.
Herron TJ; Vandenboom R; Fomicheva E; Mundada L; Edwards T; Metzger JM
Circ Res; 2007 Apr; 100(8):1182-90. PubMed ID: 17363698
[TBL] [Abstract][Full Text] [Related]
6. Size and speed of the working stroke of cardiac myosin in situ.
Caremani M; Pinzauti F; Reconditi M; Piazzesi G; Stienen GJ; Lombardi V; Linari M
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3675-80. PubMed ID: 26984499
[TBL] [Abstract][Full Text] [Related]
7. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.
Gupta MP
J Mol Cell Cardiol; 2007 Oct; 43(4):388-403. PubMed ID: 17720186
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
[TBL] [Abstract][Full Text] [Related]
9. New skeletal myopathy and cardiomyopathy associated with a missense mutation in MYH7.
Darin N; Tajsharghi H; Ostman-Smith I; Gilljam T; Oldfors A
Neurology; 2007 Jun; 68(23):2041-2. PubMed ID: 17548557
[No Abstract] [Full Text] [Related]
10. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
11. Tuning the human heart molecular motors by myosin light chains.
Morano I
J Mol Med (Berl); 1999 Jul; 77(7):544-55. PubMed ID: 10494800
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
[TBL] [Abstract][Full Text] [Related]
13. Smooth, slow and smart muscle motors.
Arner A; Löfgren M; Morano I
J Muscle Res Cell Motil; 2003; 24(2-3):165-73. PubMed ID: 14609028
[TBL] [Abstract][Full Text] [Related]
14. Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease.
Sheikh F; Lyon RC; Chen J
Gene; 2015 Sep; 569(1):14-20. PubMed ID: 26074085
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
Roopnarine O; Leinwand LA
Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
[TBL] [Abstract][Full Text] [Related]
16. Human essential myosin light chain isoforms revealed distinct myosin binding, sarcomeric sorting, and inotropic activity.
Petzhold D; Lossie J; Keller S; Werner S; Haase H; Morano I
Cardiovasc Res; 2011 Jun; 90(3):513-20. PubMed ID: 21262909
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human β-cardiac myosin.
Spudich JA; Aksel T; Bartholomew SR; Nag S; Kawana M; Yu EC; Sarkar SS; Sung J; Sommese RF; Sutton S; Cho C; Adhikari AS; Taylor R; Liu C; Trivedi D; Ruppel KM
J Exp Biol; 2016 Jan; 219(Pt 2):161-7. PubMed ID: 26792326
[TBL] [Abstract][Full Text] [Related]
19. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
[TBL] [Abstract][Full Text] [Related]
20. Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes.
Miller G; Maycock J; White E; Peckham M; Calaghan S
J Physiol; 2003 Apr; 548(Pt 1):167-74. PubMed ID: 12576501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
